Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 11, 2013, Pages 1443-1451

  Comert, S ^a   Celebioglu, E ^a   Yucel, T ^a   Erdogan, T ^a   Karakaya, G ^a   Onerci, M ^a   Kalyoncu, A F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

aspirin desensitization treatment; asthma; desensitization; rhinitis

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CORTICOSTEROID; STEROID;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DESENSITIZATION; DRUG EFFICACY; ECCHYMOSIS; FEMALE; FOLLOW UP; HUMAN; MALE; NOSE OBSTRUCTION; ODOR; POLYPECTOMY; PRIORITY JOURNAL; RHINITIS; SEVERE PERSISTENT ASTHMA; SINUSITIS; STOMACH DISEASE; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ASPIRIN DESENSITIZATION TREATMENT; ASTHMA; DESENSITIZATION; RHINITIS;

ADULT; ASPIRIN; ASTHMA; ASTHMA, ASPIRIN-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED;

EID: 84887474558     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12269     Document Type: Article

References (34)

1. Lee RU, Stevenson DD,. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011; 3: 3-10.
2. Szczeklik A, Nizankowska E, Duplaga M, on behalf of the AIANE Investigators. Natural history of aspirin-induced asthma. Eur Respir J 2000; 16: 432-436.
3. McFadden EA, Kany RJ, Fink JN, Toohill RJ,. Surgery for sinusitis and aspirin triad. Laryngoscope 1990; 100: 1043-1046.
4. Brown BL, Harner SG, Van Dellen RG,. Nasal polypectomy in patients with asthma and sensitivity to aspirin. Arch Otolaryngol 1979; 105: 413-416.
5. Rosen CA, Howell LL, Smith JD,. Efficacy of different surgical approaches in patients with aspirin sensitivity, asthma, and nasal polyposis triad. Am J Rhinol 1996; 10: 207-210.
6. Patriarca G, Bellioni P, Nucera E, Schiavino D, Papa G, Schinco G, et al. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. Ann Allergy 1991; 67: 588-592.
7. Sweet JA, Stevenson DD, Simon RA, Mathison DA,. Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990; 86: 59-65.
8. Stevenson DD, Hankammer MA, Mathison DA, Christensen SC, Simon RA,. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98: 751-758.
9. Berges-Gimeno M, Simon RA, Stevenson DD,. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180-186.
10. Stevenson DD, Simon RA,. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006; 118: 801-804.
11. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360: 985-993.
12. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360: 973-984.
13. Gosepath J, Schaefer D, Amedeee RG, Mann WJ,. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 127: 316-321.
14. Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008; 63: 1228-1234.
15. Lee JY, Simon RA, Stevenson DD,. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119: 157-164.
16. Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M, et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500-507.
17. European Academy of Allergology and Clinical Immunology. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl 2005; 18: 1-87.
18. Niżankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczyńska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111-1118.
19. Ware JE, Sherbourne CD,. The MOS 36-item short form health survey: I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
21. Johansen LV, Illum P, Kristensen S, Winther L, Petersen SV, Synnerstad B,. The effect of Budesonide in the treatment of small and medium sized nasal polyps. Clin Otolaryngol 1993; 18: 524-527.
22. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2006. Available from http://www.ginasthma.org. Date last updated, 2006.
23. Bousquet J, Van Cauwenberge P, Khaltaev N,. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-S334.
24. Berges-Gimeno M, Simon RA, Stevenson DD,. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89: 474-478.
25. Nucera E, Schiavino D, Milani A, Del Ninno M, Misuraca C, Buonomo A, et al. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies. Thorax 2000; 55: S75-S78.
26. Bruzzese N, Sica G, Iacopino F, Paludetti G, Schiavino D, Nucera E, et al. Growth inhibition of fibroblasts from nasal polyps and normal skin by lysine acetylsalicylate. Allergy 1998; 53: 431-434.
27. Scadding GK, Hassab M, Darby YC, Lund VJ, Freedman A,. Intranasal lysine aspirin in recurrent nasal polyposis. Clin Otolaryngol Allied Sci 1995; 20: 561-563.
28. Hosemann W,. Surgical treatment of nasal polyposis in patients with aspirin intolerance. Thorax 2000; 55: S87-S90.
29. Gosepath J, Mann WJ,. Aspirin intolerance and nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2002; 10: 3-7.
30. Fairley JW, Durham LH, Ell SR,. Correlation of subjective sensation of nasal patency with nasal inspiratory peak flow rate. Clin Otolaryngol 1993; 18: 19-22.
31. Sipilä J, Suonpää J, Laippala P,. Sensation of nasal obstruction compared to rhinomanometric results in patients referred for septoplasty. Rhinology 1994; 32: 141-144.
32. Simola M, Malmberg H,. Sensation of nasal airflow compared with nasal airway resistance in patients with rhinitis. Clin Otolaryngol 1997; 22: 260-262.
33. Amoore JE, Ollman BG,. Practical test kits for quantitatively evaluating the sense of smell. Rhinology 1983; 21: 49-54.
34. Cain WS,. Testing olfaction in a clinical setting. Ear Nose Throat J 1989; 68: 316,322-328.